A review of safety outcomes from clinical trials of baricitinib in rheumatology, dermatology and COVID-19 de réir Bieber, T, Feist, E, Irvine, AD, Harigai, M, Haladyj, E, Ball, S, Deberdt, W, Issa, M, Grond, S, Taylor, PC